Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist
Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist
复制标题
普拉克索(一种临床上有用的 D3 偏好多巴胺激动剂)的大鼠脑结合位点
DOI:
10.1016/0304-3940(95)11857-s
复制
发表时间:
1995
影响因子:
2.5
通讯作者:
M. Piercey
中科院分区:
文献类型:
--
作者:
Marlene Catnacho;E. L. Walker;Dawna L. Evans;M. Piercey
Pramipexole (PPX[ is currently being evaluated for treatment of schizophrenia and Parkinson's disease. In studies with cloned subtypes of the dopamine (DA[ D2receptor subfamily, PPX has higher affinity for the D3compared to the D2and D4subtypes; unlike 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT[, it does not bind to sigma sites. Receptor binding autoradiography with [3H]PPX (5 nM, 62 Ci/mmol) was used to evaluate the distribution of PPX binding sites within the rat brain. Consistent with its preference for D3-binding sites, the highest concentrations of [3H]PPX binding sites were found in the islets of Calleja (ICj), previously reported to contain D3but not D2or D4mRNA. [3H]PPX binding was also high in other mesolimbic areas such as the nucleus accumbens (N. accum), olfactory tubercle, and amygdala. [3H]PPX binding was also high in caudate (Cd), although slightly less than in mesolimbic areas. Less [3H]PPX binding sites were found in ventral tegmental area (VTA) and substantia nigra, areas rich in cell bodies for DA neurons. Thus, although PPX most potently stimulates DA autoreceptors, PPX binding sites have their highest concentrations in projection areas containing both DA terminal and postsynaptic receptors. Because of PPX's preferential affinity for the D3receptor subtype and its resultant high mesolimbic binding, it could have a unique therapeutic profile for treatment of psychiatric and/or neurological diseases.
影响因子:
5
作者:
Meller,E;Helmer-Matyjek,E;Bohmaker,K;Adler,CH;Friedhoff,AJ;Goldstein,M
通讯作者:
Goldstein,M